Quick Overview: Friends of Cancer Research Annual Meeting 2025 will spotlight pressing topics at the forefront of cancer research and regulation, ... Tatiana Prowell, MD, Breast cancer scientific liaison, FDA Oncology Center of Excellence, Silver Spring, MD. Scott Berry convenes co-authors Kert Viele, Joe Marion, and Lindsay Berry to discuss the statistical and developmental nuances ...

Session 1 Seamless Trial Designs - Detailed Overview & Context

Friends of Cancer Research Annual Meeting 2025 will spotlight pressing topics at the forefront of cancer research and regulation, ... Tatiana Prowell, MD, Breast cancer scientific liaison, FDA Oncology Center of Excellence, Silver Spring, MD. Scott Berry convenes co-authors Kert Viele, Joe Marion, and Lindsay Berry to discuss the statistical and developmental nuances ... Emily Zabor, Cancer Biostatistician at the Cleveland Clinic, presents on the Prof Susan Hilsenbeck speaks to ecancer at SABCS 2018 about modern methods of phase I Yannis Jeimiai, Vice President, Cytel Beginning with an overview of applicable adaptive approaches and the current regulatory ...

Zarah Monfaredi, Ottawa SPOR Program Facilitator, on: The Strategy for Patient-Oriented Research (SPOR): The Current States of ... ... diseases i think understanding what the population Air date: Saturday, February 19, 2022, 12PM Description: Several exciting potential treatments for ALS currently are in clinical Hear from NAMSA's Tyson Rogers on what makes an adaptive clinical Hans-Georg Eichler, Senior Medical Officer, European Medicines Agency Ben Goldacre, Wellcome Research Fellow in ...

Photo Gallery

Session 1: Seamless Trial Designs for Rare Cancer Drug Development
2016 WMIF | Focus Session: Study Designs to Meet the Challenges of Personalized Cancer Medicine
An Introduction to Phase 1 Clinical Trial Designs
Seamless designs for clinical trials: A new wave in drug development, explained
Seamless 2/3 Trial Designs
Webinar: Phase I trials in oncology: Pros and cons of current designs
Clinical Behavioural Trial Designs (e.g, adaptive/SMART, Pragmatic, n of 1, etc)
Designing Early Phase Clinical Trials with {ppseq}
Bayesian analysis in adaptive trials
Modern methods of phase 1 clinical trial design
Alternative Methods to Designing Clinical Trials in Phase 1 Oncology
Workshop: Working with Patients to Inform Early Phase Clinical Trial Design (Part 1)
Sponsored
Sponsored
View Main Result
Sponsored
Sponsored